Human B immunoglobuline (HBIG) monotherapy or combined with lamivudine (LAM) in prophylaxis of HBV recurrence after liver transplantation (LT) in HBsAg-carriers

被引：0
|
作者：
Gaia, S [1 ]
Marzano, A [1 ]
Ciardo, V [1 ]
Gentilcore, E [1 ]
Lagget, M [1 ]
Smedile, A [1 ]
Rizzetto, M [1 ]
机构：
[1] Molinette Mauriziano Hosp, Dept Gastroenterol, Turin, Italy
来源：
JOURNAL OF HEPATOLOGY | 2002年 / 36卷
关键词：
D O I：
10.1016/S0168-8278(02)80111-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
112
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [31] High efficacy of combination lamivudine and hepatitis B immunoglobulin in the prophylaxis of hepatitis B recurrence after liver transplantation.
    Ciccorossi, P
    Filipponi, F
    Oliveri, F
    Coco, B
    Colombatto, P
    Bonino, F
    Campa, M
    Mosca, F
    Brunetto, MR
    HEPATOLOGY, 2001, 34 (04) : 323A - 323A
  • [32] "Early" Conversion to Subcutaneous (SC) Human HBV-Immunoglobulins (HBIg) Is Safe and Effective in Preventing HBV Recurrence after Liver Transplantation.
    Volpes, Riccardo
    Galatioto, Laura
    Vizzini, Giovanni
    Gridelli, Bruno
    LIVER TRANSPLANTATION, 2012, 18 : S126 - S126
  • [33] Low Risk of Hepatitis B Virus (HBV) Recurrence after Withdrawal of Hepatitis B Immunoglobulin (HBIG) in a Liver Transplant(LT) Population on Oral Antivirals
    Agrawal, Nidhi
    Shechtel, Joanna L.
    Parpia, Tarina
    Fishbein, Thomas
    Shetty, Kirti
    HEPATOLOGY, 2012, 56 : 530A - 530A
  • [34] Intramuscular hepatitis B immune globulin combined with lamivudine in prevention of hepatitis B recurrence after liver transplantation
    Mao-Lin Yan
    Hepatobiliary&PancreaticDiseasesInternational, 2006, (03) : 360 - 363
  • [35] Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation
    Katz, Lior H.
    Tur-Kaspa, Ran
    Guy, Daniel G.
    Paul, Mical
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (07):
  • [36] HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation
    Kasraianfard, Amir
    Watt, Kymberly D.
    Lindberg, Lance
    Alexopoulos, Sophoclis
    Rezaei, Nima
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2016, 35 (04) : 312 - 324
  • [37] THE HEPATITIS B VIRUS (HBV) SERO-NEGATIVE CONVERSION WITH ENTECAVIR AND HIGH DOSE HBIG COMBINATION THERAPY FOR THE PATIENTS WITH HBV RECURRENCE AFTER LIVER TRANSPLANTATION
    Kim, Young-Kyu
    Lee, Kwang-Woong
    Cho, Seong Yeong
    Han, Sung-Sik
    Kim, Seong Hoon
    Kong, Sun-Young
    Lee, Yu Mi
    Park, Sang Jae
    LIVER TRANSPLANTATION, 2009, 15 (07) : S221 - S221
  • [38] TENOFOVIR PLUS EMTRICITABINE (TRUVADA) PREVENTS RECURRENCE OF HEPATITIS B VIRUS (HBV) IN LIVER TRANSPLANT (LT) RECIPIENTS AFTER DISCONTINUING HEPATITIS B IMMUNE GLOBULIN (HBIG)
    Shiffman, Mitchell L.
    Stravitz, R. Todd
    Kimmel, Melissa
    Sterling, Richard K.
    Luketic, Velimir A.
    Fisher, Robert A.
    HEPATOLOGY, 2009, 50 (04) : 392A - 392A
  • [39] Ten-year follow-up of a randomized study comparing Lamivudine vs Lamivudine plus HBIG for the prevention of Hepatitis B virus recurrence after liver transplantation
    Buti, Maria
    Mas, Antoni
    Prieto, Martin
    Casafont, Fernando
    Gonzalez, Antonio
    Miras, Manuel
    Ignacio Herrero, Jose
    Castells, Lluis
    Esteban, Rafael
    HEPATOLOGY, 2013, 58 : 238A - 239A
  • [40] Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation
    Naoumov, NV
    Lopes, AR
    Burra, P
    Caccamo, L
    Iemmolo, RM
    de Man, RA
    Bassendine, M
    O'Grady, JG
    Portmann, BC
    Anschuetz, G
    Barrett, CA
    Williams, R
    Atkins, M
    JOURNAL OF HEPATOLOGY, 2001, 34 (06) : 888 - 894
12345